Related Experiment Video
Updated: Jun 8, 2026
07:31
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Cyclooxygenase-2 expression in animal cancers.
1Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, 3200 Sicotte, St-Hyacinthe, Québec, Canada. monique.dore@umontreal.ca
Veterinary Pathology
|September 30, 2010
Summary
Cyclooxygenase-2 (COX-2) is implicated in animal cancers, but its prognostic value remains unclear. Further research is needed to determine if COX-2 is a reliable therapeutic target in veterinary oncology.
Area of Science:
- Veterinary Oncology
- Molecular Biology
- Cancer Research
Background:
- Cyclooxygenase-2 (COX-2) is a key enzyme in prostaglandin synthesis, with established roles in human cancer development.
- COX-2 is believed to contribute to oncogenesis in domestic animals, influencing processes like apoptosis, proliferation, and angiogenesis.
Purpose of the Study:
- To review current knowledge on COX-2 expression and its role in cancers affecting dogs, cats, and horses.
- To evaluate the potential of COX-2 as a prognostic factor and therapeutic target in veterinary cancers.
Main Methods:
- Literature review of existing studies on COX-2 expression in animal cancers.
- Analysis of data regarding the association between COX-2 expression, prognosis, and response to therapy.
Main Results:
- COX-2 upregulation is observed in numerous animal cancers, but its prognostic significance is not yet clearly defined.
- Limited evidence links COX-2 expression to survival in canine mammary cancers and osteosarcomas.
- COX inhibitors show potential for preventing/treating some animal cancers, such as canine urinary transitional cell carcinomas.
Conclusions:
- COX-2 expression levels are not currently reliable prognostic indicators or predictors of response to NSAID therapy in animal tumors.
- Further research, including in vitro studies, is essential to establish COX-2 as a prognostic factor and therapeutic target in veterinary oncology.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...